Search Results for “immune” – Page 86 – media

Trigger for most common form of vision loss discovered

In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight.
- Source: iran-daily
- 510
- November 30, 2017
inflammation macular degeneration Researches
Does Loss of REM Sleep Affect Overall Health?

In a recently published paper, researchers outline the importance of REM sleep and the causes and consequences of loss of REM sleep.
- Source: medicalnewsbulletin
- 473
- November 29, 2017
REM Sleep Researches Sleep deprivation
New Genes Associated With Cognitive Ability Identified

Investigators at The Feinstein Institute for Medical Research discovered dozens of new genetic variations associated with a person’s general cognitive ability. The findings, which were published online today in Cell Reports, have the potential to help researchers develop more targeted treatment for cognitive and memory disorders.
- Source: neurosciencenews
- 516
- November 29, 2017
Alzheimer's disease cognitive disorders Researches schizophrenia
Radiotherapy-resistant tumors could be defeated with experimental drugs

It may be possible to use drugs that are already in development to overcome radiotherapy resistance in tumors, which is often a major barrier to the successful treatment of many cancers.
- Source: medicalnewstoday
- 545
- November 28, 2017
cancer radiotherapy Researches tumor
Zika Virus Kills Brain Cancer Stem Cells MEDICINE & HEALTH

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine in St. Louis and the University of California San Diego School of Medicine shows that the virus kills brain cancer stem cells, the kind of cells most resistant to standard treatments.
- Source: scienmag
- 572
- November 28, 2017
brain cancer glioblastoma Researches
Bay Area’s Medeor Therapeutics Bags $57M

Medeor Therapeutics announced it had closed on an oversubscribed Series B financing worth $57 million. The round was led by RA Capital Management. New investors included Sofinnova Ventures and 6 Dimensions Capital. They were joined by existing investors Vivo Capital and WuXi Healthcare Ventures.
- Source: Biospace
- 618
- November 28, 2017
cellular immunotherapies Market Views Series
Prometic Reports Positive Interim Clinical Data From Ongoing Intravenous Immunoglobulin Pivotal Phase III Trial

Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic) announced positive interim six-month clinical data from its ongoing pivotal IVIG Phase 3 clinical trial in patients suffering from primary immunodeficiencies (PID) following review of the data by the Data Safety Monitoring Board (DSMB), which confirmed no significant safety issues and that efficacy appeared to be comparable to existing commercial IVIG products.
- Source: Prometic
- 501
- November 28, 2017
Clinical Trials IVIG PID
European Commission Approves TREMFYA® (guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union

Janssen-Cilag International NV announced that the European Commission (EC) has approved TREMFYA® (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy. Guselkumab is the first biologic that selectively blocks interleukin (IL)-23, a key driver of the immune inflammatory response in psoriasis.
- Source: Prnewswire
- 461
- November 27, 2017
interleukin Market Views plaque psoriasis TREMFYA
MS hug–What you need to know

For people with multiple sclerosis, an MS hug can be an unwelcome and painful part of their condition.
- Source: medicalnewstoday
- 670
- November 27, 2017
MS hug Researches
Study shows how gut bacteria may trigger MS

Alterations in gut bacteria at a young age could help to trigger and progress multiple sclerosis in people who are genetically predisposed to the autoimmune disease.
- Source: medicalnewstoday
- 496
- November 22, 2017
multiple sclerosis Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.